Description
Genetic Analysis Market Share, Size, Trends, Industry Analysis Report, By Type (Predictive Genetic Testing, Carrier Testing, Prenatal and Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, and Others); By Application; By Technology; By End-Use; By Region; Segment Forecast, 2023-2032 The global genetic analysis market size is expected treach USD 45.10 billion by 2032, according ta new study by Polaris Market Research. The report “Genetic Analysis Market Share, Size, Trends, Industry Analysis Report, By Type (Predictive Genetic Testing, Carrier Testing, Prenatal and Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, and Others); By Application; By Technology; By End-Use; By Region; Segment Forecast, 2023-2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.
A growing number of testing services are being developed across many countries tanalyze various types of genes that might increase or decrease the risk of diseases, including cancer and diabetes, as these tests have the potential tprevent people from common ailments and enhance the health of individuals, are major factors driving the global market growth. Furthermore, growing applications of genetic testing or analyzing services in oncology, decreasing cost of sequencing procedures, and high proliferation of innovations in the emerging genetic counseling field are likely tcreate lucrative growth opportunities.
For instance, in December 2022, HSE introduced the National Strategy for Accelerating Genetic and Genomic Medicine in Ireland. This strategy has been developed in collaboration with the Department of Health tenhance patient and family-centered genetics, which will be nationally coordinated.
There has been a significant shift from the “SNP BeadArray” chips tinnovative NGS-based services due tthe increasing affordability of the sequencing chemical & reagents. Costs associated with these advanced technologies have fallen drastically over the last few years tmake them available for many patients. For example, Illumina has announced its intent tdrive the cost of NGS down tUSD 100 per genome and will continue twork towards this goal.
Genetic Analysis Market Report Highlights
Prenatal and newborn testing segment accounted for significant global market share in 2022, on account of growing prevalence of variety of genetic diseases among infants
Cancer segment is projected tgrow at a considerable CAGR during the forecast period, because of the continuous rise in the burden of different types of cancers worldwide
Next-generation sequencing segment held the significant market revenue share in 2022, which is mainly accelerated by increasing technological advancements in several sequencing platforms
Research & development laboratories segment captured the highest market share in 2022, due ttheir ability toffer wide range of tests with higher accuracy and effectiveness
Europe region is anticipated texpand at fastest growth rate over the projected period, owing tincreasing consumer disposable income and rise in the number of government favorable initiatives
The global key market players include Bio-Rad Laboratories, Danaher Corporation, Sysmex Corporation, Agilent Technologies, and ThermFisher Scientific
Polaris Market Research has segmented the Genetic Analysis market report based on type, application, technology, end-use, and region:
Genetic Analysis, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Predictive Genetic Testing
Carrier Testing
Prenatal and Newborn Testing
Disease Diagnostic Testing
Pharmacogenomic Testing
Others
Genetic Analysis, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Cancer
Genetic Diseases
Cardiovascular Diseases
Rare Diseases
Infectious Diseases
Others
Genetic Analysis, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
Next-Generation Sequencing
Real-Time PCR System
Others
Genetic Analysis, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospitals
Research & Development Laboratories
Diagnostic Centers
Others
Genetic Analysis, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Show more
Table of Contents
1. Introduction 1.1. Report Description 1.1.1. Objectives of the Study 1.1.2. Market Scope 1.1.3. Assumptions 1.2. Stakeholders 2. Executive Summary 2.1. Market Highlights 3. Research Methodology 3.1. Overview 3.1.1. Data Mining 3.2. Data Sources 3.2.1. Primary Sources 3.2.2. Secondary Sources 4. Global Genetic Analysis Market Insights 4.1. Genetic Analysis – Industry Snapshot 4.2. Genetic Analysis Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. Increase in incidences of genetic disorders and cancer 4.2.1.2. Rise in awareness & acceptance of personalized medicines 4.2.2. Restraints and Challenges 4.2.2.1. Standardization concerns of genetic testing-based diagnostics 4.3. Porter’s Five Forces Analysis 4.3.1. Bargaining Power of Suppliers (Moderate) 4.3.2. Threats of New Entrants: (Low) 4.3.3. Bargaining Power of Buyers (Moderate) 4.3.4. Threat of Substitute (Moderate) 4.3.5. Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Genetic Analysis Industry Trends 4.6. Value Chain Analysis 4.7. COVID-19 Impact Analysis 5. Global Genetic Analysis Market, by Technology 5.1. Key Findings 5.2. Introduction 5.2.1. Global Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 5.3. Next-Generation Sequencing 5.3.1. Global Genetic Analysis Market, by Next-Generation Sequencing, by Region, 2019-2032 (USD Billion) 5.4. Real-Time PCR System 5.4.1. Global Genetic Analysis Market, by Real-Time PCR System, by Region, 2019-2032 (USD Billion) 5.5. Others 5.5.1. Global Genetic Analysis Market, by Others, by Region, 2019-2032 (USD Billion) 6. Global Genetic Analysis Market, by Application 6.1. Key Findings 6.2. Introduction 6.2.1. Global Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 6.3. Cancer 6.3.1. Global Genetic Analysis Market, by Cancer, by Region, 2019-2032 (USD Billion) 6.4. Genetic Diseases 6.4.1. Global Genetic Analysis Market, by Genetic Diseases, by Region, 2019-2032 (USD Billion) 6.5. Cardiovascular Diseases 6.5.1. Global Genetic Analysis Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Billion) 6.6. Rare Diseases 6.6.1. Global Genetic Analysis Market, by Rare Diseases, by Region, 2019-2032 (USD Billion) 6.7. Infectious Diseases 6.7.1. Global Genetic Analysis Market, by Infectious Diseases, by Region, 2019-2032 (USD Billion) 6.8. Others 6.8.1. Global Genetic Analysis Market, by Others, by Region, 2019-2032 (USD Billion) 7. Global Genetic Analysis Market, by End-use 7.1. Key Findings 7.2. Introduction 7.2.1. Global Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 7.3. Hospitals 7.3.1. Global Genetic Analysis Market, by Hospitals, by Region, 2019-2032 (USD Billion) 7.4. Research & Development Laboratories 7.4.1. Global Genetic Analysis Market, by Research & Development Laboratories, by Region, 2019-2032 (USD Billion) 7.5. Diagnostic Centers 7.5.1. Global Genetic Analysis Market, by Diagnostic Centers, by Region, 2019-2032 (USD Billion) 7.6. Others 7.6.1. Global Genetic Analysis Market, by Others, by Region, 2019-2032 (USD Billion) 8. Global Genetic Analysis Market, by Type 8.1. Key Findings 8.2. Introduction 8.2.1. Global Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 8.3. Predictive Genetic Testing 8.3.1. Global Genetic Analysis Market, by Predictive Genetic Testing, by Region, 2019-2032 (USD Billion) 8.4. Carrier Testing 8.4.1. Global Genetic Analysis Market, by Carrier Testing, by Region, 2019-2032 (USD Billion) 8.5. Prenatal and Newborn Testing 8.5.1. Global Genetic Analysis Market, by Prenatal and Newborn Testing, by Region, 2019-2032 (USD Billion) 8.6. Disease Diagnostic Testing 8.6.1. Global Genetic Analysis Market, by Disease Diagnostic Testing, by Region, 2019-2032 (USD Billion) 8.7. Pharmacogenomic Testing 8.7.1. Global Genetic Analysis Market, by Pharmacogenomic Testing, by Region, 2019-2032 (USD Billion) 8.8. Others 8.8.1. Global Genetic Analysis Market, by Others, by Region, 2019-2032 (USD Billion) 9. Global Genetic Analysis Market, by Geography 9.1. Key findings 9.2. Introduction 9.2.1. Genetic Analysis Market Assessment, By Geography, 2019-2032 (USD Billion) 9.3. Genetic Analysis Market – North America 9.3.1. North America: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.3.2. North America: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.3.3. North America: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.3.4. North America: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.3.5. Genetic Analysis Market – U.S. 9.3.5.1. U.S.: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.3.5.2. U.S.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.3.5.3. U.S.: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.3.5.4. U.S.: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.3.6. Genetic Analysis Market – Canada 9.3.6.1. Canada: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.3.6.2. Canada: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.3.6.3. Canada: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.3.6.4. Canada: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4. Genetic Analysis Market – Europe 9.4.1. Europe: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.2. Europe: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.3. Europe: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.4. Europe: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.5. Genetic Analysis Market – UK 9.4.5.1. UK: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.5.2. UK: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.5.3. UK: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.5.4. UK: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.6. Genetic Analysis Market – France 9.4.6.1. France: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.6.2. France: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.6.3. France: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.6.4. France: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.7. Genetic Analysis Market – Germany 9.4.7.1. Germany: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.7.2. Germany: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.7.3. Germany: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.7.4. Germany: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.8. Genetic Analysis Market – Italy 9.4.8.1. Italy: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.8.2. Italy: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.8.3. Italy: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.8.4. Italy: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.9. Genetic Analysis Market – Spain 9.4.9.1. Spain: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.9.2. Spain: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.9.3. Spain: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.9.4. Spain: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.10. Genetic Analysis Market – Netherlands 9.4.10.1. Netherlands: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.10.2. Netherlands: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.10.3. Netherlands: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.10.4. Netherlands: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.4.11. Genetic Analysis Market – Russia 9.4.11.1. Russia: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.4.11.2. Russia.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.4.11.3. Russia: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.4.11.4. Russia: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5. Genetic Analysis Market – Asia Pacific 9.5.1. Asia Pacific: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.2. Asia Pacific: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.3. Asia Pacific: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.4. Asia Pacific: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.5. Genetic Analysis Market – China 9.5.5.1. China: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.5.2. China.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.5.3. China: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.5.4. China: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.6. Genetic Analysis Market – India 9.5.6.1. India: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.6.2. India.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.6.3. India: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.6.4. India: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.7. Genetic Analysis Market – Japan 9.5.7.1. Japan: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.7.2. Japan.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.7.3. Japan: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.7.4. Japan: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.8. Genetic Analysis Market – Malaysia 9.5.8.1. Malaysia: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.8.2. Malaysia.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.8.3. Malaysia: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.8.4. Malaysia: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.9. Genetic Analysis Market – Indonesia 9.5.9.1. Indonesia: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.9.2. Indonesia.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.9.3. Indonesia: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.9.4. Indonesia: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.5.10. Genetic Analysis Market – South Korea 9.5.10.1. South Korea: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.5.10.2. South Korea.: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.5.10.3. South Korea: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.5.10.4. South Korea: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.6. Genetic Analysis Market – Middle East & Africa 9.6.1. Middle East & Africa: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.6.2. Middle East & Africa: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.6.3. Middle East & Africa: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.6.4. Middle East & Africa: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.6.5. Genetic Analysis Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.6.5.2. Saudi Arabia: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.6.5.3. Saudi Arabia: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.6.5.4. Saudi Arabia: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.6.6. Genetic Analysis Market – South Africa 9.6.6.1. South Africa: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.6.6.2. South Africa: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.6.6.3. South Africa: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.6.6.4. South Africa: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.6.7. Genetic Analysis Market – Israel 9.6.7.1. Israel: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.6.7.2. Israel: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.6.7.3. Israel: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.6.7.4. Israel: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.6.8. Genetic Analysis Market – UAE 9.6.8.1. UAE: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.6.8.2. UAE: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.6.8.3. UAE: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.6.8.4. UAE: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.7. Genetic Analysis Market – Latin America 9.7.1. Latin America: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.7.2. Latin America: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.7.3. Latin America: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.7.4. Latin America: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.7.5. Genetic Analysis Market – Mexico 9.7.5.1. Mexico: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.7.5.2. Mexico: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.7.5.3. Mexico: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.7.5.4. Mexico: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.7.6. Genetic Analysis Market – Brazil 9.7.6.1. Brazil: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.7.6.2. Brazil: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.7.6.3. Brazil: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.7.6.4. Brazil: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 9.7.7. Genetic Analysis Market – Argentina 9.7.7.1. Argentina: Genetic Analysis Market, by Technology, 2019-2032 (USD Billion) 9.7.7.2. Argentina: Genetic Analysis Market, by Type, 2019-2032 (USD Billion) 9.7.7.3. Argentina: Genetic Analysis Market, by Application, 2019-2032 (USD Billion) 9.7.7.4. Argentina: Genetic Analysis Market, by End-use, 2019-2032 (USD Billion) 10. Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1. Expansion 10.1.2. Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11. Company Profiles 11.1. Abbott Laboratories 11.1.1. Company Overview 11.1.2. Financial Performance 11.1.3. Product Benchmarking 11.1.4. Recent Development 11.2. Bio-Rad Laboratories 11.2.1. Company Overview 11.2.2. Financial Performance 11.2.3. Product Benchmarking 11.2.4. Recent Development 11.3. Danaher Corporation 11.3.1. Company Overview 11.3.2. Financial Performance 11.3.3. Product Benchmarking 11.3.4. Recent Development 11.4. Roche Ltd 11.4.1. Company Overview 11.4.2. Financial Performance 11.4.3. Product Benchmarking 11.4.4. Recent Development 11.5. Illumina 11.5.1. Company Overview 11.5.2. Financial Performance 11.5.3. Product Benchmarking 11.5.4. Recent Development 11.6. Myriad Genetics 11.6.1. Company Overview 11.6.2. Financial Performance 11.6.3. Product Benchmarking 11.6.4. Recent Development 11.7. Thermo Fisher Scientific 11.7.1. Company Overview 11.7.2. Financial Performance 11.7.3. Product Benchmarking 11.7.4. Recent Development 11.8. CSL Ltd. 11.8.1. Company Overview 11.8.2. Financial Performance 11.8.3. Product Benchmarking 11.8.4. Recent Development 11.9. Eurofins Scientific 11.9.1. Company Overview 11.9.2. Financial Performance 11.9.3. Product Benchmarking 11.9.4. Recent Development 11.10. Siemens Healthiniers 11.10.1. Company Overview 11.10.2. Financial Performance 11.10.3. Product Benchmarking 11.10.4. Recent Development 11.11. PerkinElmer 11.11.1. Company Overview 11.11.2. Financial Performance 11.11.3. Product Benchmarking 11.11.4. Recent Development 11.12. Sysmex Corporation 11.12.1. Company Overview 11.12.2. Financial Performance 11.12.3. Product Benchmarking 11.12.4. Recent Development 11.13. Hologic 11.13.1. Company Overview 11.13.2. Financial Performance 11.13.3. Product Benchmarking 11.13.4. Recent Development 11.14. QIAGEN 11.14.1. Company Overview 11.14.2. Financial Performance 11.14.3. Product Benchmarking 11.14.4. Recent Development 11.15. Agilent Technologies 11.15.1. Company Overview 11.15.2. Financial Performance 11.15.3. Product Benchmarking 11.15.4. Recent Development 11.16. Baylor Genetics 11.16.1. Company Overview 11.16.2. Financial Performance 11.16.3. Product Benchmarking 11.16.4. Recent Development